A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.
Clinical trial NCT05822713 · UNKNOWN
Trial details
- NCT number
- NCT05822713
- Sponsor
- Qilu Pharmaceutical (Hainan) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-29
- Primary completion
- 2023-08-31
- Enrollment
- 516
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.